ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

Nose aesthetics is among the most preferred surgical procedures worldwide due to both aesthetic concerns and health reasons.

NAD+ IonToPatch – Utilizing iontophoresis, a non-invasive transdermal drug delivery system that uses a voltage gradient to increase skin permeability, allowing for effective NAD+ absorption. The latex ...

Investors interested in arranging a meeting with the Company’s management during the conference can register on the BIO CEO & Investor Conference website here.

Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to ...

Researchers at University of the Pacific in Stockton have developed a long-acting opioid overdose-reversal drug-delivery ...

I like to do the unexpected, and I like that people will have perhaps expected that I would go more extreme,” Isamaya Ffrench tells me of the packaging on her new Core Collection of multifunctional ...

Researchers including Martin have spent years studying an alternative to direct ketamine IV injections and shots. This treatment is delivered through a nasal spray and relies not on ketamine ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions ... MAIL-ORDER KETAMINE INJECTIONS CAN BE ‘EXTREMELY DANGEROUS,’ WARNS DR.

Nasal sprays can treat congestion and other symptoms of seasonal allergies or a cold. They work by delivering a fine mist of medication into your nostrils. Since the lining of your nose is rich with ...

Botox is the most widely known brand name for botulinum toxin type A injections. Botulinum toxin is a neurotoxin made by a species of bacteria called Clostridium botulinum. It works on your nerves ...

Lively took them out of character again and began to joke about Baldoni’s nose, which he laughed off and joked in turn, even as Lively joked that he should get plastic surgery.' In Lively's ...